$5.95 0.00 (%) Compugen Ltd - NASDAQ

Dec. 5, 2016 | 03:30 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al

    TalkMarkets | Oct. 21, 2016 | 19:05PM EST
  2. Compugen Discloses Antibody Drug Conjugate Program Results at the World ADC Summit in San Diego

    Benzinga | Oct. 19, 2015 | 06:04AM EST
  3. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 24, 2015 | 07:23AM EST
  4. Morning Market Gainers

    Benzinga | Feb. 10, 2015 | 09:49AM EST
  5. Morning-Market Movers Led By Aeropostale, Coca-Cola & Coupons.Com

    Benzinga | Feb. 10, 2015 | 09:34AM EST
  6. Morning Market Gainers

    Benzinga | Feb. 9, 2015 | 09:48AM EST
  7. Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

    Benzinga | Feb. 9, 2015 | 09:05AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 9, 2015 | 08:07AM EST
  9. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 11, 2014 | 10:18AM EST
  10. Compugen Discloses Successful Validation Results For Novel B7/CD28–like Cancer Immunotherapy Target Candidate

    Benzinga | Oct. 27, 2014 | 06:06AM EST
  11. Morning Market Movers

    Benzinga | Oct. 1, 2014 | 08:39AM EST
  12. US Stock Futures Edge Lower Ahead Of ADP Report

    Benzinga | Oct. 1, 2014 | 06:38AM EST
  13. Compugen Reports Results Further Confirming CGEN-15049 as 'Promising' Target Candidate for Cancer Immunotherapy

    Benzinga | Oct. 1, 2014 | 06:10AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 8, 2014 | 07:09AM EST
  15. Benzinga's Top Initiations

    Benzinga | Jun. 18, 2014 | 08:16AM EST
  16. Morning Market Movers

    Benzinga | Jun. 16, 2014 | 08:40AM EST
  17. US Stock Futures Decline Ahead Of Economic Data

    Benzinga | Jun. 16, 2014 | 06:32AM EST
  18. Compugen Reports Positive Experimental Results for Novel Checkpoint Candidate CGEN-15052

    Benzinga | Jun. 16, 2014 | 06:05AM EST
  19. Morning Market Movers

    Benzinga | Mar. 19, 2014 | 08:36AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 19, 2014 | 07:07AM EST
  21. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
  22. Compugen Ltd. Prices 6M Share Public Offering at $10.50 per Share

    Benzinga | Feb. 28, 2014 | 09:17AM EST
  23. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 28, 2014 | 08:15AM EST
  24. Compugen to Significantly Expand Immuno-Oncology Activitiesin 2014

    Benzinga | Jan. 7, 2014 | 09:28AM EST
  25. Compugen, Bayer sign accord

    IBD | Aug. 5, 2013 | 17:43PM EST
  26. Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq Rises, Dow And S&P Fall Modestly

    Benzinga | Aug. 5, 2013 | 15:38PM EST
  27. Morning Market Movers

    Benzinga | Aug. 5, 2013 | 09:01AM EST
  28. Compugen Shares Rocket Higher as Co. Announces Collaboration, License Deal with Bayer for Antibody-Based Cancer Immunotherapies

    Benzinga | Aug. 5, 2013 | 08:21AM EST
  29. Compugen Announces Discovery of Two Novel Immune Checkpoint Targets for Cancer Immunotherapy

    Benzinga | Oct. 31, 2012 | 01:24AM EST
  30. Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance

    Benzinga | Sep. 10, 2012 | 00:05AM EST
  31. Towers Watson &, Ubiquiti Networks Among Stocks hitting 52-Week Lows Tuesday

    FoxBusiness | Aug. 14, 2012 | 05:31AM EST
  32. Compugen Says Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy

    Benzinga | Feb. 1, 2012 | 23:42PM EST
Trading Center